Neurocrine Biosciences, Inc.
DE ˙ DB ˙ US64125C1099
134,65 € ↑0,30 (0,22%)
2026-06-03
DEL PRIS
SecurityDE:NB3 / Neurocrine Biosciences, Inc.
InstitutionBokf, Na
Latest Disclosed Ownership2,193 shares
Latest Disclosed Value $ 288,906
Bokf, Na reports 1.25% increase in ownership of NB3 / Neurocrine Biosciences, Inc.

On May 8, 2026 - Bokf, Na filed a 13F-HR form disclosing ownership of 2,193 shares of Neurocrine Biosciences, Inc. (DE:NB3) valued at $245,068 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 2,166 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 1.25% during the quarter. The current value of the position is $295,287 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F NEUROCRINE BIOSCIENCES common 64125C109 2,193 27 1.25 289 -6.19 0.0034
2026-02-03 2025-12-31 13F NEUROCRINE BIOSCIENCES common 64125C109 2,166 -434 -16.69 307 -15.66 0.0047
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES common 64125C109 2,600 -13 -0.50 365 10.98 0.0055
2025-08-12 2025-06-30 13F NEUROCRINE BIOSCIENCES common 64125C109 2,613 -3,706 -58.65 328 -53.01 0.0053
2025-05-13 2025-03-31 13F NEUROCRINE BIOSCIENCES common 64125C109 6,319 2,287 56.72 699 22.89 0.0124
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES common 64125C109 4,032 13 0.32 568 26.50 0.0096
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES common 64125C109 4,019 11 0.27 450 -18.51 0.0080
2024-08-08 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,008 -23 -0.57 552 -3.16 0.0099
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,031 25 0.62 570 7.97 0.0104
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,006 27 0.68 528 19.50 0.0103
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,979 -459 -10.34 441 5.50 0.0097
2023-08-21 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,438 -252 -5.37 419 -11.81 0.0085
2023-05-11 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,690 -367 -7.26 475 -21.52 0.0099
2023-02-13 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,057 264 5.51 604 18.66 0.0111
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,793 -76 -1.56 509 7.16 0.0103
2022-08-11 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,869 71 1.48 475 5.56 0.0091
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,798 157 3.38 450 13.92 0.0074
2022-03-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,641 -851 -15.50 395 -25.05 0.0061
2021-11-10 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,492 -14,716 -72.82 527 -73.18 0.0091
2021-04-21 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,208 1,322 7.00 1,965 8.56 0.0357
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,886 -1,041 -5.22 1,810 -5.53 0.0345
2020-10-30 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,927 978 5.16 1,916 -17.13 0.0421
2020-08-12 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,949 -994 -4.98 2,312 33.95 0.0544
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,943 2,821 16.48 1,726 -6.20 0.0497
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,122 -636 -3.58 1,840 15.00 0.0416
2019-11-13 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,758 -244 -1.36 1,600 5.26 0.0385
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,002 12,455 224.54 1,520 210.84 0.0365
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,547 -10,112 -64.58 489 -56.26 0.0117
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,659 4,410 39.20 1,118 -19.16 0.0320
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,249 4,601 69.21 1,383 111.79 0.0347
2018-08-13 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,648 6,648 653 0.0176
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.